STAT Plus: Blood test maker Guardant enters race for liquid biopsy with colon cancer study
ANNIE CAVANAGH/WELLCOME
Guardant Health, whose study will include 10,000 patients, is being closely watched in the race to develop liquid biopsies.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario